| UHC Commercial Medical & Drug | Susvimo® (Ranibizumab Injection) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-08-01 |
| UHC Medicaid Medical & Drug | Complement Pathway Inhibitors – Community Plan Medical Benefit Drug Policy | 2026-08-01 |
| Aetna | Selected Kidney Function Tests | 2026-07-31 |
| Aetna | Hip Preservation Surgery | 2026-07-31 |
| Aetna | Coronary Artery Brachytherapy and Other Adjuncts to Coronary Interventions | 2026-07-30 |
| Aetna | Kidney Transplantation | 2026-07-30 |
| Aetna | Car-Ride Simulators for Infantile Colic | 2026-07-30 |
| Aetna | Intragastric Hypothermia | 2026-07-30 |
| Aetna | Urological Supplies | 2026-07-30 |
| Aetna | Vesicoureteral Reflux Treatment by Endoscopic Injection of Bulking Agents | 2026-07-30 |